In vivo DNA methylation editing in zebrafish
The CRISPR/dCas9-based epigenome editing technique has driven much attention. Fused with a catalytic domain from Dnmt or Tet protein, the CRISPR/dCas9-DnmtCD or -TetCD systems possess the targeted DNA methylation editing ability and have established a series of in vitro and in vivo disease models. H...
Main Authors: | Fang Liang, Zijiong Dong, Jianmin Ye, Wei Hu, Ramji Kumar Bhandari, Kangsen Mai, Xuegeng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Epigenetics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15592294.2023.2192326 |
Similar Items
-
Increasing Specificity of Targeted DNA Methylation Editing by Non-Enzymatic CRISPR/dCas9-Based Steric Hindrance
by: Daniel M. Sapozhnikov, et al.
Published: (2023-04-01) -
CRISPR/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer’s disease
by: Hanseul Park, et al.
Published: (2022-09-01) -
Development of super-specific epigenome editing by targeted allele-specific DNA methylation
by: Nivethika Rajaram, et al.
Published: (2023-10-01) -
Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM
by: Yunxing Liu, et al.
Published: (2021-08-01) -
Epigenetic Editing in Prostate Cancer: Challenges and Opportunities
by: Mariana Brütt Pacheco, et al.
Published: (2022-05-01)